<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(1)</volume><submitter>Das A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Type 2 diabetes mellitus (T2DM) remains a global health burden characterized by insulin resistance, persistent hyperglycaemia, and chronic inflammation. Although single-target therapies effectively reduce glucose levels, they seldom address oxidative stress or adipocyte dysfunction. Polyherbal formulations (PHFs) harness synergistic phytochemicals for multimodal intervention; however, many lack mechanistic transparency owing to excessive inclusion of diverse botanical bioactives, suffer from non-standardized composition, and underexplore volatile antidiabetic constituents. Confronting these challenges, we developed Gluco Balance V (GB5), a cold-percolated ethanolic extract comprising equal proportions of bio-effective parts of Asparagus racemosus, Cyperus rotundus, Tinos</pubmed_abstract><journal>BMC complementary medicine and therapies</journal><pagination>16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12801877</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology.</pubmed_title><pmcid>PMC12801877</pmcid><pubmed_authors>Palani P</pubmed_authors><pubmed_authors>Sundaram RL</pubmed_authors><pubmed_authors>Manigandan N</pubmed_authors><pubmed_authors>Sukumaran G</pubmed_authors><pubmed_authors>Das A</pubmed_authors><pubmed_authors>Rajeswari NC</pubmed_authors><pubmed_authors>Kuppusamy S</pubmed_authors><pubmed_authors>Veeraraghavan G</pubmed_authors></additional><is_claimable>false</is_claimable><name>GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology.</name><description>&lt;h4>Background&lt;/h4>Type 2 diabetes mellitus (T2DM) remains a global health burden characterized by insulin resistance, persistent hyperglycaemia, and chronic inflammation. Although single-target therapies effectively reduce glucose levels, they seldom address oxidative stress or adipocyte dysfunction. Polyherbal formulations (PHFs) harness synergistic phytochemicals for multimodal intervention; however, many lack mechanistic transparency owing to excessive inclusion of diverse botanical bioactives, suffer from non-standardized composition, and underexplore volatile antidiabetic constituents. Confronting these challenges, we developed Gluco Balance V (GB5), a cold-percolated ethanolic extract comprising equal proportions of bio-effective parts of Asparagus racemosus, Cyperus rotundus, Tinos</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T14:58:37.389Z</modification><creation>2026-06-01T03:08:13.653Z</creation></dates><accession>S-EPMC12801877</accession><cross_references><pubmed>41382285</pubmed><doi>10.1186/s12906-025-05192-3</doi></cross_references></HashMap>